Alignment Healthcare price to free cash flow ALHC
Market value divided by free cash flow over the last twelve months, since 2025.
- Today, Oct 23, 2026
- 9.4×
- Peer median
- 11.7×
Alignment Healthcare's price to free cash flow is 9.4× as of Oct 23, 2026.
The median for 10 healthcare stocks of a similar size is 11.7×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 9.4× | 8.8× | 38.3× |
| 2025 | 25.0× | 21.7× | 164× |
Against its peers
Companies in Healthcare nearest Alignment Healthcare's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| ALHCAlignment Healthcare | 9.4× |
| ANIPANI Pharmaceuticals | 9.6× |
| ARDTArdent Health | 5.7× |
| HCSGHealthcare Services | 11.7× |
| PAHCPhibro Animal Health | 160× |
| EYENational Vision | 30.1× |
| CNMDCONMED | 11.0× |
| PNTGPennant | 42.2× |
| ANABAnaptysbio | n/m |
| PCRXPacira BioSciences | 8.1× |
| LMATLemaitre Vascular | 26.2× |
| Peer median | 11.7× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Alignment Healthcare
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.